|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2003-6-6
|
|
pubmed:abstractText |
The aim of this study was to do an initial assessment of the usefulness of 2beta-carbomethoxy-3beta-(4-chlorophenyl)-8-(2-(18)F-fluoroethyl)nortropane ((18)F-FECNT) PET scanning in determining in vivo brain dopamine transporter (DAT) density in healthy humans and subjects with Parkinson's disease (PD).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/2-carbomethoxy-3-(4-chlorophenyl)-8-...,
http://linkedlifedata.com/resource/pubmed/chemical/Dopamine Plasma Membrane Transport...,
http://linkedlifedata.com/resource/pubmed/chemical/Fluorine Radioisotopes,
http://linkedlifedata.com/resource/pubmed/chemical/Ligands,
http://linkedlifedata.com/resource/pubmed/chemical/Membrane Glycoproteins,
http://linkedlifedata.com/resource/pubmed/chemical/Membrane Transport Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Nerve Tissue Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Nortropanes,
http://linkedlifedata.com/resource/pubmed/chemical/Radiopharmaceuticals,
http://linkedlifedata.com/resource/pubmed/chemical/SLC6A3 protein, human
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0161-5505
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
44
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
855-61
|
|
pubmed:dateRevised |
2005-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:12791810-Adult,
pubmed-meshheading:12791810-Aged,
pubmed-meshheading:12791810-Brain,
pubmed-meshheading:12791810-Dopamine Plasma Membrane Transport Proteins,
pubmed-meshheading:12791810-Feasibility Studies,
pubmed-meshheading:12791810-Female,
pubmed-meshheading:12791810-Fluorine Radioisotopes,
pubmed-meshheading:12791810-Humans,
pubmed-meshheading:12791810-Ligands,
pubmed-meshheading:12791810-Male,
pubmed-meshheading:12791810-Membrane Glycoproteins,
pubmed-meshheading:12791810-Membrane Transport Proteins,
pubmed-meshheading:12791810-Metabolic Clearance Rate,
pubmed-meshheading:12791810-Middle Aged,
pubmed-meshheading:12791810-Nerve Tissue Proteins,
pubmed-meshheading:12791810-Nortropanes,
pubmed-meshheading:12791810-Parkinson Disease,
pubmed-meshheading:12791810-Radiopharmaceuticals,
pubmed-meshheading:12791810-Tomography, Emission-Computed
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Initial human PET imaging studies with the dopamine transporter ligand 18F-FECNT.
|
|
pubmed:affiliation |
PET Center, Emory University, Atlanta, Georgia, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Controlled Clinical Trial,
Validation Studies
|
